Mark Deneau

1.6k total citations · 1 hit paper
20 papers, 563 citations indexed

About

Mark Deneau is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Deneau has authored 20 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Hepatology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Deneau's work include Liver Diseases and Immunity (12 papers), Gallbladder and Bile Duct Disorders (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (7 papers). Mark Deneau is often cited by papers focused on Liver Diseases and Immunity (12 papers), Gallbladder and Bile Duct Disorders (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (7 papers). Mark Deneau collaborates with scholars based in United States, Canada and United Kingdom. Mark Deneau's co-authors include Linda Book, Stephen L. Guthery, John Holmén, Kyle K. Jensen, Marc S. Williams, Christopher L. Bowlus, David N. Assis, M. Kyle Jensen, Mercedes Martínez and Annika Bergquist and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Mark Deneau

18 papers receiving 556 citations

Hit Papers

AASLD practice guidance on primary sclerosing cholangitis... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Deneau United States 10 430 315 309 168 72 20 563
Paul J. Kingma Netherlands 4 413 1.0× 315 1.0× 276 0.9× 240 1.4× 89 1.2× 8 553
Edward Alabraba United Kingdom 10 264 0.6× 265 0.8× 178 0.6× 132 0.8× 25 0.3× 21 496
Sjoerd de Rave Netherlands 8 311 0.7× 282 0.9× 162 0.5× 47 0.3× 62 0.9× 12 448
B Uzunalimoğlu Türkiye 14 201 0.5× 189 0.6× 158 0.5× 64 0.4× 25 0.3× 29 429
Kristine Wiencke Norway 9 176 0.4× 103 0.3× 99 0.3× 63 0.4× 51 0.7× 17 283
Akiko Fujiwara Japan 10 124 0.3× 71 0.2× 144 0.5× 52 0.3× 33 0.5× 28 320
Jean-Christophe Valats France 11 97 0.2× 251 0.8× 116 0.4× 153 0.9× 60 0.8× 17 369
S. Yedibela Germany 14 298 0.7× 303 1.0× 145 0.5× 219 1.3× 41 0.6× 31 559
Luis Abreu Spain 9 60 0.1× 191 0.6× 127 0.4× 119 0.7× 118 1.6× 19 331
Stella Gabeta Greece 15 471 1.1× 171 0.5× 439 1.4× 16 0.1× 21 0.3× 27 597

Countries citing papers authored by Mark Deneau

Since Specialization
Citations

This map shows the geographic impact of Mark Deneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Deneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Deneau more than expected).

Fields of papers citing papers by Mark Deneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Deneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Deneau. The network helps show where Mark Deneau may publish in the future.

Co-authorship network of co-authors of Mark Deneau

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Deneau. A scholar is included among the top collaborators of Mark Deneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Deneau. Mark Deneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fevery, Johan, Douglas G. Adler, Annika Bergquist, et al.. (2024). Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD. Journal of Pediatric Gastroenterology and Nutrition. 80(3). 450–454.
2.
Kastenberg, Zachary J., Mark Deneau, Elizabeth O’Brien, et al.. (2023). Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study. The Journal of Pediatrics. 257. 113339–113339. 7 indexed citations
3.
Bowlus, Christopher L., Lionel Arrivé, Annika Bergquist, et al.. (2022). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 77(2). 659–702. 152 indexed citations breakdown →
4.
Ponsioen, Cyriel Y., David N. Assis, Kirsten Muri Boberg, et al.. (2021). Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology. 161(6). 1764–1775.e5. 41 indexed citations
5.
Taylor, Mark A., et al.. (2020). Ketorolac after colectomy for ulcerative colitis in children: An analysis of opioid utilization and postoperative complications. Journal of Pediatric Surgery. 55(11). 2393–2396.
6.
Jensen, M. Kyle, et al.. (2019). Treatment of primary sclerosing cholangitis in children. World Journal of Hepatology. 11(1). 19–36. 20 indexed citations
7.
Johnson, Erin, et al.. (2019). A Novel Care Model for Neonatal Intestinal Failure Patients Is Associated With Cost Savings and Improved Outcomes. Gastroenterology Research. 12(2). 93–95. 1 indexed citations
8.
Putnam, Angelica R., et al.. (2019). Neonatal cholestasis and hepatosplenomegaly caused by congenital dyserythropoietic anemia type 1: A case report. World Journal of Hepatology. 11(5). 477–482. 2 indexed citations
9.
Deneau, Mark, et al.. (2019). Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. The Journal of Pediatrics. 215. 144–151.e3. 8 indexed citations
10.
Deneau, Mark, et al.. (2018). Implementing a Standardized Constipation-Management Pathway to Reduce Resource Utilization. Academic Pediatrics. 18(8). 957–964. 7 indexed citations
11.
Soufi, Nisreen, Fateh Bazerbachi, & Mark Deneau. (2018). Post-Transplant Disease Recurrence in Pediatric PSC. Current Gastroenterology Reports. 20(9). 44–44. 5 indexed citations
12.
Deneau, Mark, et al.. (2017). Reducing hospital admissions of healthy children with functional constipation: a quality initiative. BMJ Open Quality. 6(2). e000116–e000116. 4 indexed citations
13.
Saubermann, Lawrence J., Mark Deneau, Richard A. Falcone, et al.. (2016). Hepatic Issues and Complications Associated With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 64(4). 639–652. 24 indexed citations
14.
Jensen, M. Kyle, et al.. (2015). Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases. 22(1). 146–150. 17 indexed citations
15.
Mhanni, Aizeddin A., et al.. (2015). Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease. SHILAP Revista de lepidopterología. 6. 13–15. 10 indexed citations
16.
Jiménez‐Rivera, Carolina, Simon C. Ling, Najma Ahmed, et al.. (2015). Incidence and Characteristics of Autoimmune Hepatitis. PEDIATRICS. 136(5). e1237–e1248. 69 indexed citations
17.
Deneau, Mark, Linda Book, Stephen L. Guthery, & M. Kyle Jensen. (2014). Outcome after Discontinuation of Immunosuppression in Children with Autoimmune Hepatitis: A Population-Based Study. The Journal of Pediatrics. 164(4). 714–719.e2. 19 indexed citations
18.
Deneau, Mark, Kyle K. Jensen, John Holmén, et al.. (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in utah children: Epidemiology and natural history. Hepatology. 58(4). 1392–1400. 156 indexed citations
19.
Deneau, Mark, Douglas G. Adler, Jason J. Schwartz, et al.. (2011). Cholangiocarcinoma in a 17‐year‐old Boy With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 52(5). 617–620. 9 indexed citations
20.
Deneau, Mark, Stephen L. Guthery, Molly O’Gorman, et al.. (2010). Natural Killer Cell Lymphoma in a Pediatric Patient With Inflammatory Bowel Disease. PEDIATRICS. 126(4). e977–e981. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026